TabsDetailsBasic DetailsDate Posted: Thursday, July 27, 2017Status: CompleteMedical Product: tetanus, diphtheria, pertussis (Tdap) vaccineHealth Outcome(s): pertussisDescription: CBER has requested execution of the pregnancy tool to determine the number of pregnant women/episodes with a Tdap vaccination. This a feasibility assessment to determine if Sentinel data can provide enough sample size/power to be used to resolve regulatory concerns, such as the investigation of the impact of Tdap vaccination of pregnant women on the rates of pertussis in children in a full PBA. Read More Deliverables (1)Sentinel Modular Program Report: Tdap Vaccination During Pregnancy Additional InformationAdditional DetailsFDA Center: CBERTime Period: January 1, 2010 - September 30, 2015Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All pregnant females 10 - 54 years of ageData Sources: Sentinel Distributed Database (SDD)Related Links: ICPE 2017 Poster: Trends of Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccination During Pregnancy in the Sentinel SystemContributorsWorkgroup Leader(s): Alison Kawai, ScD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MAWorkgroup Members: Genna Panucci, MPH; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
